Patient Perception Questionnaire Validation
Validation of the Patient Perception Questionnaire
1 other identifier
observational
217
1 country
1
Brief Summary
Validation of the patient perception questionnaire relating to CPAP use
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2011
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2012
CompletedFirst Submitted
Initial submission to the registry
September 12, 2013
CompletedFirst Posted
Study publicly available on registry
February 20, 2014
CompletedResults Posted
Study results publicly available
July 15, 2020
CompletedJuly 15, 2020
July 1, 2020
10 months
September 12, 2013
August 10, 2017
July 13, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
To Determine the Association of the Participants Baseline PPQ (Patient Perception Questionnaire) Responses to Predict Adherence to CPAP Treatment at 90 Days.
The PPQ is a custom questionnaire including 10 questions evaluating perceptions of OSA and CPAP treatment. Each question is derived from models of psychology such as self-regulatory ability and social support. Q1 ranges from 0-10, with 10 indicating OSA negatively impacts life. Q2 ranges from 0-10, with 10 indicating belief that OSA will last forever. Q3 ranges from 0-10, with 10 indicating that CPAP is extremely necessary to control OSA. Q4 ranges from 1-10, with 10 indicating no intention of using CPAP at all. Q5 ranges from 1-10, with 10 indicating presence of a highly supportive spouse. Q6 ranges from 1-10, with 10 indicating benefit of CPAP is well understood. Q7 ranges from 0-10, with 10 indicating extreme concern about using CPAP. Q8 ranges from 1-10, with 10 indicating high confidence with using CPAP. Q9 ranges from 1-10, with 10 indicating high perception that CPAP will help treat OSA. Q10 ranges from 1-10, with 10 indicating spouses negative attitude toward CPAP use.
Baseline and 90 days
Secondary Outcomes (2)
Adherence to CPAP Treatment
14 Days, 60 Days, 90 Days
Reliability of Patient Perception Questionnaire
14 days, 60 days, 90 days
Study Arms (1)
Obstructive Sleep Apnea
Interventions
Eligibility Criteria
OSA patients
You may qualify if:
- Mild-severe OSA patients
- Over 18
- Naive to CPAP
- Fluent english
You may not qualify if:
- Comorbidities
- Other sleep disorders
- Inability to tolerate CPAP
- Shift worker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clayton Sleep Institute
St Louis, Missouri, 63143, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Clinical Research Scientist
- Organization
- Fisher and Paykel Healthcare
Study Officials
- PRINCIPAL INVESTIGATOR
Eric Powell
Clayton Sleep Institute
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 12, 2013
First Posted
February 20, 2014
Study Start
April 1, 2011
Primary Completion
February 1, 2012
Study Completion
April 1, 2012
Last Updated
July 15, 2020
Results First Posted
July 15, 2020
Record last verified: 2020-07